Incyte (INCY) Inventory Average (2012 - 2026)
Incyte posted quarterly Inventory Average of $108.3 million for Q1 2026, up 76.39% year-on-year from $61.4 million in Q1 2025, and up 17.47% on a QoQ basis from $92.2 million in Q4 2025.
Incyte (INCY) has 15 years of Inventory Average data on file, last reported at $108.3 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 76.39% year-over-year to $108.3 million; the trailing twelve-month figure through Mar 2026 stood at $108.3 million (up 76.39% YoY), and the FY2025 full-year result was $80.0 million, up 31.26% from the prior year.
- Inventory Average for Q1 2026 stood at $108.3 million, up from $92.2 million in the prior quarter.
- Across five years, Inventory Average topped out at $108.3 million in Q1 2026 and bottomed at $31.7 million in Q1 2022.
- The 5-year median for Inventory Average is $61.4 million (2025), against an average of $63.1 million.
- The widest annual swing landed in 2022, when Inventory Average jumped 169.66%; it then declined 14.69% in 2023.
- A 5-year view of Inventory Average shows it stood at $43.9 million in 2022, then surged by 36.77% to $60.1 million in 2023, then advanced by 7.61% to $64.7 million in 2024, then jumped by 42.65% to $92.2 million in 2025, then advanced by 17.47% to $108.3 million in 2026.
- The last three Inventory Average figures came in at $108.3 million (Q1 2026), $92.2 million (Q4 2025), and $83.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 108.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.34 Mn |
| Dec 31, 2025 | 92.23 Mn |
| Sep 30, 2025 | 83.41 Mn |
| Jun 30, 2025 | 73.70 Mn |
| Mar 31, 2025 | 61.42 Mn |
| Dec 31, 2024 | 64.66 Mn |
| Sep 30, 2024 | 85.57 Mn |
| Jun 30, 2024 | 82.15 Mn |
| Mar 31, 2024 | 63.29 Mn |
| Dec 31, 2023 | 60.09 Mn |
| Sep 30, 2023 | 46.55 Mn |
| Jun 30, 2023 | 38.39 Mn |
| Mar 31, 2023 | 41.44 Mn |
| Dec 31, 2022 | 43.93 Mn |
| Sep 30, 2022 | 50.18 Mn |
| Jun 30, 2022 | 45.00 Mn |
| Mar 31, 2022 | 31.70 Mn |
| Dec 31, 2021 | 24.60 Mn |
| Sep 30, 2021 | 18.99 Mn |
| Jun 30, 2021 | 16.69 Mn |
| Mar 31, 2021 | 16.56 Mn |
| Dec 31, 2020 | 16.71 Mn |
| Sep 30, 2020 | 16.65 Mn |
| Jun 30, 2020 | 15.14 Mn |
| Mar 31, 2020 | 12.69 Mn |
| Jun 30, 2019 | 6.83 Mn |
| Mar 31, 2019 | 7.05 Mn |
| Dec 31, 2018 | 6.48 Mn |
| Sep 30, 2018 | 5.93 Mn |
| Jun 30, 2018 | 5.25 Mn |
| Mar 31, 2018 | 5.56 Mn |
| Dec 31, 2017 | 4.87 Mn |
| Sep 30, 2017 | 3.10 Mn |
| Jun 30, 2017 | 3.45 Mn |
| Mar 31, 2017 | 4.03 Mn |
| Dec 31, 2016 | 4.09 Mn |
| Sep 30, 2016 | 5.10 Mn |
| Jun 30, 2016 | 3.72 Mn |
| Mar 31, 2016 | 1.55 Mn |
| Dec 31, 2015 | 2.11 Mn |
| Sep 30, 2015 | 2.16 Mn |
| Jun 30, 2015 | 2.16 Mn |
| Mar 31, 2015 | 1.39 Mn |
| Dec 31, 2014 | 380,000.00 |
| Sep 30, 2014 | 335,500.00 |
| Jun 30, 2014 | 308,000.00 |
| Mar 31, 2014 | 376,500.00 |
| Dec 31, 2013 | 382,500.00 |
| Sep 30, 2013 | 246,000.00 |
| Jun 30, 2013 | 161,000.00 |
| Mar 31, 2013 | 233,500.00 |
| Dec 31, 2012 | 234,000.00 |
| Sep 30, 2012 | 189,000.00 |